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Objective: To estimate the prevalence of Chlamydia trachomatis, C. psittaci and C. pneumoniae antibodies in sera from 
altogether 931 blood donors, patients with symptoms of urethritis, assumed salpingitis and sexually acquired reactive 
arthritis (SARA), and women with fertility problems. 
Methods: IgG antibodies to  C. trachomatis, C. psittaci and C. pneumoniae were determined by microimmuno- 
fluorescence (MIF) tests. All patients were also tested for genital C. trachomatis infection using direct immuno- 
fluorescence (DIF) tests. 
Results: The DIF-positive cases had a significantly ( p  < 0.0001) higher prevalence of C. trachomatis antibodies than the 
DIF negatives, i.e. 88.5% versus 14% in men with urethritis, 94.3% versus 36.4% in women with salpingitis, 66.7% versus 
16.7% in SARA patients and 90.6% versus 20.8% in  women with fertility problems. Antibody reactivity t o  all three 
chlamydial species was found significantly ( p  < 0.0001) more often in the patient groups and in those with a DIF- 
confirmed genital C. trachomatis infection than in  blood donors. 
Conclusions: Presence of serum antibodies to  C. trachornatis is tightly associated with the presence of chlamydiae in 
the genital tract, which also influences the cross-reactivities occurring in the MIF tests between chlamydial species. 
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INTRODUCTION 
The genus Chlamydia comprises four species, i.e. 
Chlamydia trachomatis, C. psittaci, C. pneumoniae and C. 
yecovum [ 11. Chlamydiae are small obligate intracellular 
bacteria that may cause infections in humans and 
in animals. Altogether, 18 human serotypes of C. 
trachoniatis are known [2], while no subdivision of the 
other species has been agreed upon. 
C. tvachounatis is a frequent cause of both compli- 
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cated and non-complicated genital tract infections 131. 
In the industrialized countries tuba1 occlusion is found 
in up to 14-40% of female partners in couples seeking 
medical advice because of fertility problems 141. 
Damage to the fallopian tubes, occurring after 
chlamydial pelvic inflammatory disease (PID), may lead 
to ectopic pregnancy and infertility [5,6]. In societies 
with a high prevalence of C. trachomatis infections, up 
to three-quarters of all PID cases are caused by C. 
trachomatis infection [7]. 
Sexually acquired reactive arthritis (SARA) is 
another complication of infections with C. trachomatis. 
About 50-75% of patients with SARA either have 
antibodies against C. trachomatic or harbor the agent in 
the genital tract [S]. 
Great differences in the prevalence of serum 
antibodies to C. trackomatis have been demonstrated in 
various study populations. Thus only 4% of a series of 
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blood donors in the UK had such antibodies [9], while 
93% of women attending an abortion clinic in the USA 
had antibodies to C. trachomatis [lo]. 
C. prittaci is known to cause diseases in more than 
16 species of mammals and 130 species of birds. 
Infections by C. psittaci in humans are mainly zoonoses 
acquired from pets or farm animals. Those obtained 
from birds mainly result in pneumonia [1 11. Contacts 
with infected mammals may result in pneumonia, 
arthritis, endocarditis and abortion in pregnant women 
who have come into contact with infected cattle [12]. 
C. pneumoniae causes infections of the upper and 
lower respiratory tract in humans, e.g. sinusitis, 
pharyngitis, bronchitis and pneumonia [13]. A possible 
role of this species in myocardial infarction, 
atherosclerosis and asthma has recently been considered 
Serum antibodies that cross-react with antigens 
from one or more chlamydial species complicate the 
evaluation in case detection and serologic studies. 
The most common chlamydial serum antibodies are 
those reacting with C. pneumoniae, occurring at  a high 
prevalence in most communities. 
Our study was aimed to: (a) establish the pre- 
valence of antibody reactivity to one or more 
chlamydial species in blood donors and in patients 
consulting for symptoms of urethritis, assumed 
salpingitis or SARA, as well as in women with fertility 
problems; (b) compare the prevalence of antibodies to 
C. trachomatis and antibodies to all three chlamydial 
species in those with and without direct immuno- 
fluorescence (DIF)-confirmed genital C. trachomatis 
infection. 
[ 1 4-1 61. 
MATERIALS AND METHODS 
Study population 
Two groups of Lithuanians (n = 931) were selected for 
the study: (a) blood donors and (b) patients attending 
the Venereal Disease Hospital, University Clinic 
in Vilnius and the Center of Infertility in Kaunas 
(Lithuania). 
The first group comprised 468 blood donors 
(median age 31 years). Of  these, 294 were males 
(median age 32 years) and 174 females (median age 31 
years), attending the Blood Center in Vilnius. The 
blood donors claimed to be healthy at the time of blood 
donation and were not undergoing any antibiotic 
treatment. 
The second study group comprised 462 patients 
(median age 31 years) who had consulted health-care 
units because of signs of genital tract infections: 102 
men with urethritis (median age 24 years), 57 women 
with assumed salpingitis (median age 24 years), and 192 
patients with SARA (median age 35 years), of whom 
111 were males (median age 36 years) and 81 were 
females (median age 35 years). Also studied were 112 
women with fertility problems (median age 32 years) 
who had tried to get pregnant for at least 2 years. 
The study populations were divided into 10-year 
age groups from, i.e. 18 to 58 years. 
All patients were also tested for the presence of C. 
trachomatis antigen by DIF tests (SYVA MicroTrak 
Chlamydia trackomatis Direct Specimen Test, SYVA 
Company, San Jose, CA, USA). Male urethral and 
female cervical and urethral swabs were tested. 
Serum samples 
Blood was collected by venopuncture. The samples 
were kept for 1 h at  37 "C for better fibrin cloth 
formation, followed by incubation at  4 "C for better 
serum separation. After centrifugation at 230 g for 
20 min, sera were collected and kept at  -70 OC until 
investigated (up to 2 to 3 months at the most). 
Chlamydia1 antigens 
The antigens for the microimmunofluorescence (MIF) 
tests were prepared from yolk sacs of hen's embryos, 
which had died 5 to 12 days after infection with C. 
trachomatis (serovar La, strain 434), C. psittaci (strain 
6BC) and C. pneumoniae (IOL-207). Ten percent 
suspensions (w/v) in sucrose-phosphate (2-SP) buffer 
[17] were prepared. The suspensions were vortexed 
(Protherm pt9000, Sci. Ind., Inc., Bohemia, NY, USA) 
for 3 min with glass beads and sonicated twice for 
1 min in an ultrabath (Branson 2200, Branson 
Ultrasonics Corp., Connecticut, USA). Each suspen- 
sion was centrifuged at 13,000 x g for 60 min and the 
pellet was resuspended in 2-SP buffer to 1/10 of the 
original volume. 
Serial dilutions of the antigen were made. Five 
microliters of each dilution were placed on a glass slide, 
allowed to air-dry and fixed with cold (4 "C) acetone. 
The DIF tests were performed on all antigens using the 
IMAGENTM Chlamydia DIF test (DAKO Diagnostics 
Ltd, UK). The kit consists of monoclonal antibodies 
against chlamydial lipopolysaccharide (LPS). As LPS 
possesses genus-specific reactivity, it will detect anti- 
bodies to all chlamydial species. The tests were 
performed according to the manufacturer's instruc- 
tions. The working dilution selected was the highest 
dilution of antigen ensuring a fluorescence of grade 3+ 
to 4+. As positive controls, human sera, reacting only 
with antigen of one chlamydial species, selected from 
previous experiments, were used. 
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Microimmunofluorescence tests 
Each serum sample was tested for the presence of anti- 
chlamydial IgC antibodies in twofold dilutions (1/32 to 
1/2048) in phosphate-buffered saline (PBS) (pH 7.4). 
Four 1 pl antigen dots, i.e. of C. trachomatis, C. psittaci, 
C. prieumoniae and the negative control, were placed in 
each well on a 10-well glass slide (ICN Biomedicals 
Inc., Ohio, USA), using 10-pl disposable micro- 
pipettes (Wiretrol, Drummond Sci. Comp., Broomal, 
Pennsylvania, USA). Non-infected yolk sac antigen was 
prepared in the same way as the chlamydial antigens and 
included as a negative control. 
After 10 min of acetone fixation, antigens were 
overlaid with diluted sera and incubated for 30 min at 
37 O C .  After washing twice for 5 min with PBS 
(pH 7.4) and for 10 s with distilled water and following 
fan-drying, the glass slides were incubated for 60 min 
a t  37 O C  with fluorescein isothiocyanate (FITC)- 
labeled mice antihuman IgG secondary antibody 
(Dakopatts A/S, Glostrup, Denmark). After repeated 
washing, the tests were read under a NIKON (Japan) 
fluorescence microscope ( ~ 4 0 0 ) .  
The cut-off value for the MIF test was 1/32. 
Statistical analysis 
Any difference between groups of data was calculated 
by the chi-squared test, using the JMP program for the 
Macintosh (SAS Institute Inc., NC,  USA). 
RESULTS 
Antibodies to Chlamydia frachomatis 
The prevalences of sera reacting with C. truchomatir 
antigen from the blood donors and patients with 
urethritis, assumed salpingitis, SARA and involuntary 
childlessness are shown in Table 1. 
The prevalence of sera reacting with C. truchomatis 
antigen among the blood donors was 30.3%. This was 
Table 1 Prevalence and geometric mean titers (GMT) of 
Chlamydia  tvachomatis IgG antibodies in blood donors and 
patients with symptoms of urethritis, assumed salpingitis 
and sexually acquired reactive arthritis (SARA), and women 
with fertility problems 
GMT of IgG 
C. trarhomatis C. trachomatis 





































* p = 0.001 (difference from female blood donors); chi-square test. 
** p = 0.0001 (difference from female blood donors); chi-rquare 
test. 
significantly ( p  > 0.02) more common among the 
women than in the men, i.e. 36.8% versus 26.596, 
respectively (Table 1). 
Significantly more infertile women ( p  = 0.0001) 
and those with assumed salpingitis ( p  = 0.002) had IgC 
antibody reactivity to C. trachomatis than in female 
blood donors. In female SARA patients the prevalence 
was similar to that in the female blood donors 
(Table 1). 
Among the male urethritis patients 54.9% had 
antibodies to C. trachomutis. This prevalence was 
significantly ( p  < 0.0001) higher than in the blood 
donors (26.5%). However, the prevalence of IgG anti- 
body reactivity to C. trachomatis in the male patients 
with SARA was similar to that in the blood donors, i.e. 
30.7%. 
The DIF-positive patients had a significantly 
( p  < 0.0001) higher prevalence of sera reacting with 
Table 2 The prevalence and geometric mean titers (GMT) of IgG antibodies to Chlamydia  tvachomatis antigens, and the 
percentage of serum samples with antibodies to three chlaniydial antigens of DIF-positive and DIF-negative patients with 
urethritis, assumed salpingitis, and sexually acquired reactive arthritis (SARA), and women with fertility problems 
Serum with 
GMT of IgG of C. trachornatis antibodies to 
C. trathomatis IgG positive three chlaniydial 
Group Total number (%) antibohes species ("A) 
- - - + + + + - 
Urcthritis 52 (51.0) 50 (49.1)) 181* 49 88.5" 14 63.5* 2.0 
Salpingitir 35 (61.4) 22 (38.6) 221* 83 94.3* 36.4 57.1** 13.6 
SARA 54 (28.1) 138 (71.9) 96* 55 66.7" 16.7 25.9* 3.6 
64.0* 1 2 5  Infertility 64 (57.1) 48 (42.9) 209* 56 90.6* 20.8 
* p < 0.0001 (difference from DIF negativer, respectively); chi-square tmt. 
** p = 0.002 (difference from DIF negatives, respectively); chi-square test. 
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Table 3 Influence of age on the prevalence of Chlamydia 
trachomatis IgG antibodes in blood donors 
Age groups Total C. trachomatis IgG 
(median age) no. positive (oh) 
~ 
18-28 (24) 177 33.3 
29-38 (33) 181 38.1 
39-48 (42) 86 13.9 
49-58 (52) 24 8 3  
C. tvachomatis antigen as compared to the DIF-negative 
cases, which was true in all of the groups tested (Table 
2). The highest prevalence was observed in DIF- 
positive patients with assumed salpingitis (94.3%), 
followed by the DIF-confirmed urethritis and infertility 
cases, with prevalences around 90%. The DIF-positive 
patients consulting for SARA had a lower prevalence 
of such antibodies (i.e. 66.7%), but this prevalence was 
still significantly higher than that of the whole SARA 
group (i.e. 30.7%). 
The geometric mean titers (GMTs) of IgG 
antibodies reacting with C. trackomatis antigen were 
similar in the blood donor- and the SARA groups 
(Table 1). In the DIF-positive patients with urethritis, 
assumed salpingitis and or fertility problems, the GMTs 
were much higher than in the corresponding DIF- 
negative patients (Table 2). In the SARA patients, the 
GMT was the same for both these two latter groups. 
Table 3 shows the relationship of IgG antibodies 
reacting with C. truchomatis antigen to age, in 10-year 
intervals from 18 years of age, among the blood donors. 
The younger age groups (18 to 28 and 29 to 38 years) 
had antibodies to C. trachomatis in 33.3% and 38.1%, 
which was significantly more frequent ( p <  0.0001) 
than in those who were older (39 to 48 and 49 to 58 
years), i.e. 8.3-13.9%. Significantly ( p  = 0.02) more 
females (44.6%) than males (26.8%) had antibodies with 
reactivity against C. trachomatic antigen in the youngest 
age group (median age 24 years), while in those with 
an age of 29 to 38 years ( n  = 181), the prevalences were 
similar between the sexes, i.e. 37% for the females and 
38.9% for the males. 
In the men with urethritis and in the SARA 
patients there were lower prevalences of antibodies to 
C. trachomatis in the older age groups (data not shown), 
but in the women with salpingitis and fertility problems 
there were no such differences. 
Antibodies to Chlamydia pneumoniae 
Table 4 shows the prevalence and GMTs of IgG 
antibody reactivity against C. pneumoniae and C. psittaci. 
Antibodies reacting with C. pneumoniae antigen 
were detected in 76.5% of the blood donors. There was 
no significant difference in the prevalence between the 
sexes in the blood donors. Similar prevalences were also 
found in the other groups studied. There were also no 
significant differences in the GMTs among the different 
groups studied. In the men with urethritis, the 
salpingitis group and the women with fertility problems 
the prevalence of antibodies to C. pneurnoniae was 
slightly lower in younger than in older age-groups, but 
this difference was not significant (data not shown). 
Antibodies to Chlamydia psittaci 
The prevalences of antibodies reacting with C. psittaci 
antigen were similar in the blood donors and in patients 
with SARA, but higher in those with urethritis, 
assumed salpingitis and fertility problems (Table 4). 
No significant differences in the prevalence of 
antibodies to C. ysittaci between male and female blood 
donors were found. The GMTs did not differ between 
the blood donors and the patients with urethritis, 
assumed salpingitis and SARA. Females had higher 
GMTs than males. No significant differences between 
the age groups were found, except for the SARA 
patients, where no antibodies were found in the 49-58- 
year-old (n = 7) age group (data not shown). 
Table 4 Prevalence and geometric mean titers (GMTs) of Chlamydia pneumoniae and Chlamydia psittaci IgG antibodies in 
blood donors and patients with urethritis, assumed salpingitis and SARA, and women with fertility problems 
C. pneumoniae GMT of IgG of C. psittaci IgG GMT of IgG 
Health status IgG positive (%) C. pneumoniae positive (oh) of C. prittaci 
Blood donors 76.5 167 17.7 103 
Males 78.2 174 20.1 84 
Females 73.6 160 16.7 159 
Urethritis 78.4 212 38.2 75 
Salpingitis 68.4 193 38.6 86 
SARA 70.8 178 11.5 60 
Males 68.5 164 12.6 43 
Females 74.1 20 1 9.9 108 
Infertility 83.8 234 49.1 178 
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Antibodies to one or more chlamydial species 
Species-specific antibodies to C. tvachomatis were found 
in 1.7% of the blood donors. More female than male 
blood donors had such antibodies, but the difference 
was not significant ( p  = 0.1). Antibodies reacting with 
C. trachomatis, but not with antigen of any other species, 
were found in approximately 2% of the serum samples 
of the remaining groups studied. No differences with 
regard to age were found. 
Species-specific antibodies to C. pneumoniae were 
detected in 45.5% of the blood donors, with higher 
prevalence in the males than in the females, i.e. in 50% 
and 37.996, respectively ( p  = 0.01). The prevalences of 
such antibodies in patients with urethritis, salpingitis 
and SAKA, and in women with fertility problems, 
were 23.596, 10.5%, 40.1%) and 23.1%, respectively. 
The prevalences of antibodies reacting with C. 
pneumoniae slightly increased with age in most of the 
groups studied (data not shown). 
Species-specific antibodies to C. psittari were found 
in 1.1% of the blood donors (2.3% in men and 0.6% 
in women). Among women with salpingitis the 
prevalence of such antibodies was 1.7%, while in the 
other groups studied such antibodies were not detected. 
All cases with antibodies reacting only with C. psittac-i 
were found in the 29-38-year age group of salpingitis 
patients ( n  = 12) and in the 18-28-year age-group of 
the blood donors. 
An antibody reactivity against only one of the three 
chlamydial antigens studied occurred more often in the 
blood donors and the SARA patients (in 48.1% and 
42.7% of cases) than in the other groups (in 14.0% to 
around 260/0 of cases). This was also the case in the DIF- 
positive patients, where antibodies reacting with only 
one species were found in 29.6% of the SARA patients, 
but in only approximately 7% in the other patient 
groups. 
Antibodies reacting with two chlamydia1 antigens 
were found in 19-33'%, of cases studied. Most often, 
i.e. in 153/930 (16.4%), the combination of antibody 
reactivity to C. trachomatis and C. pneunzoniae occurred, 
followed by C. pneumoniae and C. psittaci reactivity, i.e. 
27/930 (2.9%). More seldom, the combination of 
antibody reacting against both C. trachomatis and C. 
psittaci antigen, i.e. 10/930 (1.1%) was found. 
The percentages of serum samples reacting with all 
three of C. trachomatis, C. pneutnoniae and C. psittaci 
antigens were 33.396, 40.3% and 42.0% in the patients 
with symptoms of urethritis, assumed salpingitis and 
fertility problems, respectively. These prevalences were 
at  least three times higher than in the blood donors 
(p<0.0001). In SARA patients this reactivity pattern 
was the least common, i.e. in 9.9'%, of the cases. This 
reactivity pattern was not influenced by age in most of 
the study populations, except in the blood donors and 
in the SARA patients, where higher prevalences ofsuch 
antibodies were found in the younger than the older 
age-groups. 
The titers of antibodies to C. trachomatis in the 
DIF-positive cases in all groups were significantly 
(p<O.OOOl) higher than in L)IF-negative cases. The 
GMTs for C. trachomatis antibodies are shown in Table 
2. Significantly more patients with a DIF-confirmed 
genital chlamydial infection than DIF-negative ones 
among the men with urethritis (p<O.O001), women 
with assumed salpingitis (p=0.002), the SAKA paticnts 
(p<0.0001) and women with fertility problems 
( p <  0.0001) possessed reactivity to all three chlamydia1 
species (Table 2). 
DISCUSSION 
The prevalence of infections due to chlamydiae in 
eastern Europe, including the Baltic states, hac been 
poorly studied [18-201. No screening for such 
infections seems yet to have been done in these areas. 
However, the studies that have been performed until 
now indicate that genital tract infections due to (1. 
trachomatis are common, as in many other parts of the 
world. For example, in Lithuania, C. tvachornatis hac 
been detected by DIF tests in 57% of patients with non- 
gonococcal urethritis (NGU), in 44% of patients 
with Reiter's syndrome and in 49% of other sexually 
transmitted disease (STD) clinic patients [19]. Our 
earlier studies in Lithuanians demonstrated chlamydial 
infection in 58% of men consulting with symptoms 
suggestive of a STD [21], but only in 6-18% of those 
attending the same clinic for other reasons [22,23]. In 
only one study has the prevalence of C. ynrtrrnoniae 
antibodies in a population of an eastern European 
country, i.e. Hungary, been reported [ l X ] ,  namely in 
75.2%) of blood donors. 
We found that antibodies reacting with C. 
trachomatis occurred, regardless of age, more often in the 
females than in the males. This was the case both in the 
blood donors and in the older groups studied. This 
corresponds to previous reports on blood donors [9] 
and patients attending genitourinary medicine clinics 
1241. One explanation for this gender difference might 
be that the antigenic stimulation in women is stronger, 
particularly if the upper female genital tract is engaged. 
Local mucosal stimulation such as in urethritis in males 
may be less effective [25]. 
C. traclzomatis infections generally have the highest 
prevalence in young, sexually active groups. Among the 
blood donors, antibodies were most often dctccted in 
the groups with a median age of 24 and 33 years. This 
peak age is somewhat higher than in the corresponding 
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study populations. Antibodies that react with C. 
trackomatis antigen were detected more often in the 
younger females than in the males studied. This fits 
with the general knowledge that women start having 
sex earlier than men. 
Among patients consulting with symptoms of 
urethritis, the prevalence of antibodies reacting to C. 
trachomatis antigen was 54.9%. This prevalence in 
the group of unselected urethritis patients may be 
explained by urethritis caused by Neisseria gonourhoeae, 
which is still common in Lithuania. O n  the other hand, 
the IgG C. trachomatis antibody prevalence was as high 
as 88.5% if only the DIF-positive cases among the 
urethritis patients were considered. The low prevalence 
of antibodies reacting with this chlamydial species in 
the patients consulting with arthritis (SARA) might be 
likewise explained by the fact that C. trackomatis is not 
the only cause of this disease. In Lithuania the relative 
proportion of SARA cases induced by C. trachomatis 
may be lower than in western Europe. A higher 
prevalence of antibodies reacting to C. trachomatis was 
found in the DIF-positive than in the DIF-negative 
cases, which seems to increase the likelihood of an 
etiologic role of C. trachomatis in SARA. 
The prevalence of antibodies reacting with C. 
trachomatir in the women with salpingitis and fertility 
problems was twice as high as in the female blood 
donors. The prevalence was three to four times higher 
in the C. trachomatis DIF-positive patients than in the 
DIF-negatives. Similar observations have also been 
made by others [26,27]. 
The prevalence of sera reacting with only C. 
trachomati3 antigen among our patients with urethritis, 
assumed salpingitis and SARA, and women with fertility 
problems, differs from that reported in cases with 
genital, ocular genital, or oculogenital C. trachomatis 
infection in London [25], i.e. 2.2% versus 23.5%. This 
difference probably reflects differences in study popu- 
lations chosen, i.e. non-selected patients consulting 
STD departments (in our study) versus patients with 
culture-proven (ocu1o)genital C. trachomatis infection. 
A much higher frequency of antibodies reacting 
only with C. pneumoniae was found in our study, 
i.e. 28.8%, than in London, i.e. 1% [XI. Apart from 
epidemiologic differences, different strains may have 
been used to prepare the test antigen. 
Not only the prevalences, but also the GMTs, of 
IgG antibodies reacting to C. trachomatis were highest 
in the salpingitis patients. The GMTs were also higher 
in C. trachomatis DIF-positive than in DIF-negative 
cases. High GMTs of C. trachomatis antibodies in 
salpingitis patients were also shown by others, indica- 
ting that the GMT strongly correlates with the severity 
of tuba1 damage [27]. 
IgG serum antibody reactivity to C. trachomatis was 
shown in 30.3% of our blood donors (in 36.8% of the 
females and in 26.5% of the males). This study group 
was without symptoms and signs of disease at  the time 
of blood donation. The serum antibodies detected, to 
any of the chlamydial species, seem to represent an 
anamnestic response, although chronic asymptomatic 
infection by C. frachomatis in some of the cases could 
not be ruled out. 
The prevalence of antibodies to C. pneumoniae was 
high in all groups tested, i.e. 70-83%, which may mean 
that most adults undergo challenge and rechallenge 
with this agent or with some other chlamydial 
species or with other agent(s) cross-reacting with 
C. pneumoniae repeatedly during their lifetime. The 
results of our study of Lithuanians are similar to those 
obtained in Hungary [18] and Denmark [28], where 
the prevalence of C. pneumoniae antibodies was shown 
to be 80%. However, such prevalence figures lack 
significance if the study group is not age defined, 
because prevalence is correlated to the age distribution. 
There were no significant differences between sex and 
age groups with regard to the prevalence of 
serum antibody reactivity against C. pneumoniae, 
which was in contrast to previous findings by some 
other workers 1291, who have found males to more 
often have such an antibody reactivity than the females. 
I t  can only be speculated whether this difference could 
be explained by differences in exposure between eastern 
Europe and the USA and western Europe, differences 
in smoking and other habits, or differences in reactivity 
to the strain used as antigen in the MIF test. 
In our study significantly more sera with antibody 
reactivity to all three chlamydial species were found in 
patients as compared to blood donors. This type of 
reactivity was also found significantly more often in 
urethritis, assumed salpingitis, infertility and SARA 
patients with DIF-confirmed genital C. trachomatis 
infection than in DIF-negative cases. 
Others [30] have also demonstrated that IgG 
antibodies reacting with chlamydial LPS, as defined by 
ELISA using a genus-specific epitope of LPS, occur 
significantly more fiequently in culture-positive patients 
than in culture-negative patients with urethritis and 
cervicitis. 
Because infection by C. psittaci is a zoonosis, 
the prevalence of C. psitiaci antibodies is very much 
dependent on the occupation of the study population, 
place of habitation (rural or urban) and percentage of 
animal holders. In Lithuania, the percentage of people 
involved in farming is greater than in, for example, 
most western European countries. 
In our study a prevalence of antibodies reacting 
with C. psittaci of about 20% was found. Even higher 
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prevalences have been found in other populations; 
for example, 36% of adults in Sudan had such anti- 
body reactivity [31J. In professional occupational risk 
groups, e.g. pet shop holders and slaughterhouse 
staff, prevalence figures up to 50%) have been reported 
C. prittaci antibody reactivity was more common in 
the urethritis, assumed salpingitis and fertility problem 
groups than in the blood donors and the SARA 
patients. A higher number of sera in the three former 
groups exhibited a genus-specific reactivity pattern, 
which influenced the detected prevalence. In other 
words, an ongoing genital C. trackomatis infection seems 
to influence the prevalence of detectable antibody 
reactivity to C. p i t t a r i  as seen in MIF tests. 
Sera with IgG antibodies reacting with only one of 
the C. trackomatis, C. psittaii and C. pneuinoniae antigens 
in the blood donors occurred in 1.796, 0.2% and 45.5% 
of the cases, respectively. Reactivities to only one 
of these species is more likely to reflect a previous 
infections [33], while presence of antibodies reacting 
against two different chlamydial species indicates two 
independent infections [24,33]. 
When the same sera reacted against two chlamydial 
species, presence of antibodies to C. trarkomatir and C. 
pneurrroniar was the most common combination. This 
has also previously been found in a Swedish study [33]. 
The present study did not investigate antibody 
reactivity to C. pecorum (recently separated from C. 
prit taci) .  The possibility of antibodies being formed 
against this species that cross-react with the other 
chlamydia1 species studied should also be considered, 
although so far no human infections with this species 
have been diagnosed. Likewise, cross-reactivity to 
another not yet detected species of Chlamydiae may 
also occur. 
In the blood donors, more antibodies reacting only 
with C. pnenmoriiae antigen were found in the men than 
in the women, which is consistent with findings by 
others [29J. 
Generally, the MIF test mainly detects antibodies 
directed to surface-exposed, type-specific epitopes 
on the major outer membrane protein (MOMP) of 
Chlamydiae. However, reactivity against the genus 
(group)-specific LPS antigen does also occur. When 
the same sera react with more than one chlamydia1 
species, the presence of antibodies to a few chlamydial 
species or an LPS-type of reactivity should be suspected 
LPS-induced reactivity is proposed to occur 
during the acute phase of chlaniydial infection when 
species-specific antibody epitopes are hidden, while 
species-specific antibodies can be detected during the 
reconvalescence period [33]. Therefore, seroepidemio- 
[321. 
133-351. 
logic studies may overestiniatc the prevalence of infcc- 
tion by any chlamydial species. 
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